title: Efavirenz-associated breast hypertrophy in HIV-infection patients.
authors.affiliation: Clinique de Médecine Interne et Maladies Infectieuses, H pital Haut-Léveque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France.
authors.forename: P
authors.initials: P
authors.lastname: Mercié
authors.forename: J F
authors.initials: JF
authors.lastname: Viallard
authors.forename: R
authors.initials: R
authors.lastname: Thiébaut
authors.forename: I
authors.initials: I
authors.lastname: Faure
authors.forename: P
authors.initials: P
authors.lastname: Rispal
authors.forename: B
authors.initials: B
authors.lastname: Leng
authors.forename: J L
authors.initials: JL
authors.lastname: Pellegrin
mesh_terms: D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D001941:Breast Diseases / Q000139:chemically induced*; D003521:Cyclopropanes; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz